Reproducible and efficient murine CNS gene delivery using a microprocessor-controlled injector

Journal of Neuroscience Methods

Volumn 80, Issue 2, 1998, Pages 137-147

  Brooks, Andrew I ^a   Halterman, Marc W ^a   Chadwick, Christopher A ^a   Davidson, Beverly L ^b   Haak Frendscho, Mary ^c   Radel, Clyde ^d   Porter, Chris ^d   Federoff, Howard J ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c PROMEGA CORPORATION   (United States)

^d WORLD PRECISION INSTRUMENTS INC   (United States)

Author keywords

Adenovirus; DNA; Gene therapy; Gene transfer; Herpes simplex virus; Liposomes

Indexed keywords

GALACTOSIDASE;

ADENOVIRUS; ANIMAL CELL; ARTICLE; DELETION MUTANT; EXPRESSION VECTOR; GENE TARGETING; HERPES SIMPLEX VIRUS; INFUSION PUMP; MICROPROCESSOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS MUTATION;

ADENOVIRIDAE; ANIMALS; CENTRAL NERVOUS SYSTEM; DNA, VIRAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, VIRAL; GENETIC VECTORS; HERPES SIMPLEX; LIPOSOMES; MICE; MICROCOMPUTERS; MICROINJECTIONS; REPRODUCIBILITY OF RESULTS; SIMPLEXVIRUS; STEREOTAXIC TECHNIQUES; VIRAL STRUCTURAL PROTEINS;

EID: 0032580253     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(97)00207-0     Document Type: Article

References (24)

1. Akli S., Caillaud C., Vigne E., Stratford-Perricauder L.D., Poenaru L., Perricaudet M., Kahn A., Peschanski M.R. Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet. 3:1993;224-228.
2. Andersen, J., Breakefield, X. In: Wolfe J, editor. Somatic Gene Therapy. CRC Press, Inc., 1995;135-160.
3. Bajocchi G., Feldman S., Crystal R., Mastrangeli A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat Genet. 3:1993;229-234.
4. Bergold, P., Casaccia-Bonnefil, P., Federoff, H., Stelzer, A., Transduction of CA3 neurons by a herpes virus vector containing a GluR6 subunit of the kainate receptor induces epileptiform discharge. Soc Neuro Abstr, Washington, DC, 1993.
5. Brody S., Crystal R. Adenovirus-mediated in vivo gene transfer. Ann NY Acad Sci. 716:1994;90-101.
6. Brooks A., Muhkerjee B., Panahian N., Cory-Slechta D., Federoff H. Nerve growth factor somatic mosaicism produced by herpes virus-directed expression of cre recombinase. Nature Biotechnology. 15:1997;57-62.
7. Davidson B., Allen E., Kozarsky K., Wilson K., Roessler B. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet. 3:1993;219-223.
8. During M., Naegele J., O'Malley K., Geller A. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science. 266:1994;1399-1403.
9. Federoff, H. In: Viral Vectors. New York: Academic Press, Inc., 1995;109-117.
10. Federoff H., Geschwind M., Geller A., Kessler J. Expression of nerve growth factor in vivo, from a defective HSV-1 vector prevents effects of axotomy on sympathetic ganglia. Proc Natl Acad Sci USA. 89:1992;1636-1640.
11. Geller A., Breakefield X. A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons. Science. 241:1988;1667-1669.
12. Geller A., During M., Haycock J., Freese A., Neve R. Long-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a herpes simplex virus type 1 vector. Proc Natl Acad Sci USA. 90:1993;7603-7607.
13. Geschwind M., Hartnick C.J., Liu W., Amat J., VanDeWater T.R., Federoff H.J. Defective HSV-1 vector expressing BDNF in auditory ganglia elicits neurite outgrowth: model for treatment of neuron loss following cochlear degeneration. Hum Gene Ther. 7:1996;173-182.
14. Geschwind M, Lu B, Federoff H. In: Conn P, editor. Providing Pharmacological Access to the Brain; A volume of Methods in Neurosciences, Vol. 21. Orlando, Florida: Academic Press, Inc., 1994;462-482.
15. Glorioso J, Goins W, Meaney C, Fink D, DeLuca N. Gene transfer to brain using herpes simplex virus vectors. Ann Neurol 1994;Suppl 35:S28-S34.
16. Ho DY, Fink SL, Lawrence MS, Meier TJ, Saydam TC, Dash R, Sapolsky RM Herpes simplex virus vector system: analysis of its in vivo and in vitro cytopathic effects. J Neurosci Methods. 57:1995;205-215.
17. Horellou P, Vigne E, Castel MN, Barneoud P, Colin P, Perricaudet M, Delaere P, Mallet J Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of parkinson's disease. Neuroreport. 6:1994;49-53.
18. Hurwitz D.R., Chinnadurai G. Evidence that a second tumor antigen coded by adenovirus early gene region E1a is required for efficient cell transformation. Proc Nat Acad Sci. 82:1985;163-167.
19. Jin BK, Belloni M, Conti B, Federoff HJ, Starr R, Son JH, Baker H, Jon TH et al. Long-term in vivo gene expression driven by a tyrosine hydroxylase promoter in a defective herpes simplex virus amplicon vector. Human Gene Therapy. 7:1996;2015-2024.
20. Johnson P., Miyanohara A., Levine F., Cahill T., Friedmann T. Cytotoxicity of a replication-defective mutant of herpes simplex virus type I. J Virol. 66:1992;2952-2965.
21. Johnson P., Wang M., Friedmann T. Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function. J Virol. 68:1994;6347-6362.
22. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet. 8:1994;148-154.
23. Linnik M., Zahos P., Geschwind M., Federoff H. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke. 26:1995;1670-1675.
24. Paterson T., Everett R. A prominent serine-rich region in Vmw175, the major transcriptional regulator protein of herpes simplex virus type 1, is not essential for virus growth in tissue culture. J Gen Virol. 71:1990;1775-1783.